<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35544535</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">1932-6203</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>17</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
            </PubDate>
          </JournalIssue>
          <Title>PloS one</Title>
          <ISOAbbreviation>PLoS One</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Etiology of meningitis among adults in three quaternary hospitals in Mozambique, 2016-2017: The role of HIV.</ArticleTitle>
        <Pagination>
          <StartPage>e0267949</StartPage>
          <MedlinePgn>e0267949</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">e0267949</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0267949</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Meningitis remains an important cause of morbi-mortality in adults in sub-Saharan Africa. Data on the etiological investigation of meningitis in adults in Mozambique is limited and most studies were conducted in southern Mozambique. Identification of the etiology of meningitis in adults are crucial to guide prevention and treatments strategies. In this study, we determine the burden of fungal and bacterial meningitis among adults at the three largest hospitals in Mozambique.</AbstractText>
          <AbstractText Label="METHOD" NlmCategory="METHODS">We performed analysis of data from the routine sentinel surveillance system for meningitis in Mozambique from January 2016 to December 2017. Cerebrospinal fluid (CSF) samples were collected from eligible adults (≥18 years old) who met World Health Organization (WHO) case definition criteria for Meningitis. All samples were tested by cryptococcal antigen (CrAg) lateral flow assay (LFA), culture and triplex real-time polymerase chain reaction (qPCR) assay and all patients were tested for human immunodeficiency virus (HIV) using the national algorithm for HIV testing.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Retrospective analysis of 1501 CSF samples from adults clinically suspected of meningitis revealed that 10.5% (158/1501) were positive for bacterial and fungal meningitis. Of these 158 confirmed cases, the proportion of Cryptococcal meningitis and pneumococcal meningitis was38.6% (95% CI: 31.0% to 46.7%) and 36.7% (95% CI: 29.2% to 44.7%), respectively. The other bacterial agents of meningitis identified include Neisseria meningitidis (8.9%; 14/158), Escherichia coli (6.3%; 10/158), Haemophilus influenzae (5.1%; 8/158) and S. aureus (4.4%; 7/158), which represent (24.7%; 39/158) of the total confirmed cases.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Altogether, our findings show a high burden of Cryptococcal meningitis among adults in Mozambique, especially in people living with HIV, followed by pneumococcal meningitis. Our findings suggest that rollout of CrAg Lateral Flow Assay in the health system in Mozambique for early detection of cryptococcus neoformans is necessary to improve overall patient care.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Nhantumbo</LastName>
            <ForeName>Aquino Albino</ForeName>
            <Initials>AA</Initials>
            <Identifier Source="ORCID">0000-0002-1244-0332</Identifier>
            <AffiliationInfo>
              <Affiliation>Laboratório de Bacteriologia e Patógenos de Alto Risco, Instituto Nacional de Saúde, Ministério da Saúde, Maputo, Mozambique.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Comé</LastName>
            <ForeName>Charlotte Elizabeth</ForeName>
            <Initials>CE</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratório de Bacteriologia e Patógenos de Alto Risco, Instituto Nacional de Saúde, Ministério da Saúde, Maputo, Mozambique.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maholela</LastName>
            <ForeName>Plácida Iliany</ForeName>
            <Initials>PI</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto Nacional de Saúde, Ministério da Saúde, Maputo, Mozambique.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Munguambe</LastName>
            <ForeName>Alcides Moniz</ForeName>
            <Initials>AM</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratório de Bacteriologia e Patógenos de Alto Risco, Instituto Nacional de Saúde, Ministério da Saúde, Maputo, Mozambique.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Costa</LastName>
            <ForeName>Paulino da</ForeName>
            <Initials>PD</Initials>
            <AffiliationInfo>
              <Affiliation>Unidade de Gestão de Dados, Instituto Nacional de Saúde, Ministério da Saúde, Maputo, Mozambique.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mott</LastName>
            <ForeName>Mariana</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-3459-7277</Identifier>
            <AffiliationInfo>
              <Affiliation>Universidade Federal de Ciências de Saúde de Porto Algre (UFCSPA), Porto Alegre, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cunha</LastName>
            <ForeName>Gabriella Rosa</ForeName>
            <Initials>GR</Initials>
            <Identifier Source="ORCID">0000-0002-2580-2494</Identifier>
            <AffiliationInfo>
              <Affiliation>Universidade Federal de Ciências de Saúde de Porto Algre (UFCSPA), Porto Alegre, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chambal</LastName>
            <ForeName>Lúcia</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Medicina at the Hospital Central de Maputo, Ministério da Saúde, Maputo, Mozambique.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dias</LastName>
            <ForeName>Cícero</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Universidade Federal de Ciências de Saúde de Porto Algre (UFCSPA), Porto Alegre, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cantarelli</LastName>
            <ForeName>Vlademir Vicente</ForeName>
            <Initials>VV</Initials>
            <AffiliationInfo>
              <Affiliation>Universidade Federal de Ciências de Saúde de Porto Algre (UFCSPA), Porto Alegre, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Universidade Feevale, Novo Hamburgo, RS, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gudo</LastName>
            <ForeName>Eduardo Samo</ForeName>
            <Initials>ES</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto Nacional de Saúde, Ministério da Saúde, Maputo, Mozambique.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>PLoS One</MedlineTA>
        <NlmUniqueID>101285081</NlmUniqueID>
        <ISSNLinking>1932-6203</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000946">Antigens, Fungal</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000946" MajorTopicYN="N">Antigens, Fungal</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003454" MajorTopicYN="Y">Cryptococcus</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003455" MajorTopicYN="Y">Cryptococcus neoformans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015658" MajorTopicYN="Y">HIV Infections</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016919" MajorTopicYN="Y">Meningitis, Cryptococcal</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008586" MajorTopicYN="Y">Meningitis, Pneumococcal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009073" MajorTopicYN="N" Type="Geographic">Mozambique</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013211" MajorTopicYN="N">Staphylococcus aureus</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>13</Hour>
          <Minute>45</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35544535</ArticleId>
        <ArticleId IdType="pmc">PMC9094547</ArticleId>
        <ArticleId IdType="doi">10.1371/journal.pone.0267949</ArticleId>
        <ArticleId IdType="pii">PONE-D-21-23940</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Rajasingham R, Smith RM, Park BJ, Jarvis JN, Govender NP, Chiller TM, et al.. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis. 2017; 17 (8):873–81. doi: 10.1016/S1473-3099(17)30243-8 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1473-3099(17)30243-8</ArticleId>
            <ArticleId IdType="pmc">PMC5818156</ArticleId>
            <ArticleId IdType="pubmed">28483415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clinical microbiology reviews. 2010; 23(3):467–92. Epub 2010/07/09. doi: 10.1128/CMR.00070-09 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.00070-09</ArticleId>
            <ArticleId IdType="pmc">PMC2901656</ArticleId>
            <ArticleId IdType="pubmed">20610819</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oordt-Speets AM, Bolijn R, van Hoorn RC, Bhavsar A, Kyaw MH (2018) Global etiology of bacterial meningitis: A systematic review and meta-analysis. PLoS ONE
13(6): e0198772. doi: 10.1371/journal.pone.0198772
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0198772</ArticleId>
            <ArticleId IdType="pmc">PMC5995389</ArticleId>
            <ArticleId IdType="pubmed">29889859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nuoh R.D., Nyarko K.M., Nortey P., Sackey S.O., Lwanga N.C., Ameme D.K., et al.. (2016) Review of Meningitis Surveillance Data, Upper West Region, Ghana 2009–2013. Pan African Medical Journal, 25, 9. doi: 10.11604/pamj.supp.2016.25.1.6180
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.11604/pamj.supp.2016.25.1.6180</ArticleId>
            <ArticleId IdType="pmc">PMC5292117</ArticleId>
            <ArticleId IdType="pubmed">28210377</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meiring S, Cohen C, Quan V, et al.. HIV infection and the epidemiology of invasive pneumococcal disease (IPD) in South African adults and older children prior to the introduction of a pneumococcal conjugate vaccine (PCV). Plos One. 2016;11:e0149104. doi: 10.1371/journal.pone.0149104
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0149104</ArticleId>
            <ArticleId IdType="pmc">PMC4749259</ArticleId>
            <ArticleId IdType="pubmed">26863135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cordonnier C, Averbuch D, Maury S, et al.. Pneumococcal immunization in immunocompromised hosts: where do we stand?
Expert Rev Vaccines. 2014;13:59–74. doi: 10.1586/14760584.2014.859990
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1586/14760584.2014.859990</ArticleId>
            <ArticleId IdType="pubmed">24308578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Madhi SA, Nunes MC. The potential impact of pneumococcal conjugate vaccine in Africa: considerations and early lessons learned from the South African experience. Hum Vaccin Immunother. 2016;12:314–325. doi: 10.1080/21645515.2015.1084450
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/21645515.2015.1084450</ArticleId>
            <ArticleId IdType="pmc">PMC5049711</ArticleId>
            <ArticleId IdType="pubmed">26317537</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>WHO. Defeating Meningitis by 2030: A Global Road Map. Available online: https://www.who.int/docs/defaultsource/immunization/meningitis/defeatingmeningitisroadmap.pdf (accessed on 20 April 2021).</Citation>
        </Reference>
        <Reference>
          <Citation>BD 2016 Meningitis Collaborators. Global, regional, and national burden of meningitis, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018. 
Dec;17(12):1061–1082. doi: 10.1016/S1474-4422(18)30387-9 Epub 2018 Nov 13. ; PMCID: PMC6234314.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1474-4422(18)30387-9</ArticleId>
            <ArticleId IdType="pmc">PMC6234314</ArticleId>
            <ArticleId IdType="pubmed">30507391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Durski KN, Kuntz KM, Yasukawa K, et al.. Cost-effective diagnostic checklists for meningitis in resource-limited settings. J Acquir Immune Defic Syndr
2013; 63:e1018.5. doi: 10.1097/QAI.0b013e31828e1e56
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/QAI.0b013e31828e1e56</ArticleId>
            <ArticleId IdType="pmc">PMC3683123</ArticleId>
            <ArticleId IdType="pubmed">23466647</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deiss R, Loreti CV, Gutierrez AG, Filipe E, Tatia M, Issufo S, et al.. (2021) High burden of cryptococcal antigenemia and meningitis among patients presenting at an emergency department in Maputo, Mozambique. PLoS ONE
16(4): e0250195. doi: 10.1371/journal.pone.0250195
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0250195</ArticleId>
            <ArticleId IdType="pmc">PMC8075188</ArticleId>
            <ArticleId IdType="pubmed">33901215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization. Guidelines for the diagnosis, prevention, and management of cryptococcal disease in HIV-infected adults, adolescents and children, March 2018: supplement to the 2016 consolidated guidelines of the use of antiretroviral drugs for treating and preventing HIV infection.</Citation>
        </Reference>
        <Reference>
          <Citation>Siedner MJ, Ng CK, Bassett IV, Katz IT, Bangsberg DR, Tsai AC. Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002–2013: a meta-analysis. Clin Infect Dis. 2015;60(7):1120–7. doi: 10.1093/cid/ciu1137
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/ciu1137</ArticleId>
            <ArticleId IdType="pmc">PMC4366582</ArticleId>
            <ArticleId IdType="pubmed">25516189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Veltman JA, Bristow CC, Klausner JD. Meningitis in HIV-positive patients in sub-Saharan Africa: a review. J Int AIDS Soc. 2014; 17(1):19184. doi: 10.7448/IAS.17.1.19184
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7448/IAS.17.1.19184</ArticleId>
            <ArticleId IdType="pmc">PMC4195174</ArticleId>
            <ArticleId IdType="pubmed">25308903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berhe T, Melkamu Y, Amare A. The pattern and predictors of mortality of HIV/AIDS patients with neurologic manifestation in Ethiopia: a retrospective study. AIDS Res Ther. 2012; 9(1). doi: 10.1186/1742-6405-9-11
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1742-6405-9-11</ArticleId>
            <ArticleId IdType="pmc">PMC3348055</ArticleId>
            <ArticleId IdType="pubmed">22490062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jarvis JN, Meintjes G, Williams A, Brown Y, Crede T, Harrison TS. Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases. BMC Infect Dis. 2010;10:67. doi: 10.1186/1471-2334-10-67
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2334-10-67</ArticleId>
            <ArticleId IdType="pmc">PMC3161361</ArticleId>
            <ArticleId IdType="pubmed">20230635</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wall EC, Everett DB, Mukaka M, Bar-Zeev N, Feasey N, Jahn A, et al.. Bacterial meningitis in Malawian adults, adolescents, and children during the era of antiretroviral scale-up and Haemophilus influenzae type B vaccination, 2000–2012. Clin Infect Dis. 2014;58(10):e137–45. doi: 10.1093/cid/ciu057
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/ciu057</ArticleId>
            <ArticleId IdType="pmc">PMC4001285</ArticleId>
            <ArticleId IdType="pubmed">24496208</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Veltman JA, Bristow CC, Klausner JD. Meningitis in HIV-positive patients in sub-Saharan Africa: a review. J Int AIDS Soc. 2014; 17(1):19184. doi: 10.7448/IAS.17.1.19184
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7448/IAS.17.1.19184</ArticleId>
            <ArticleId IdType="pmc">PMC4195174</ArticleId>
            <ArticleId IdType="pubmed">25308903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cresswell FV, Bangdiwala AS, Bahr NC
et al.. Tuberculous meningitis diagnosis and outcomes during the Xpert MTB/Rif era: a 6.5-year cohort study in Uganda [version 2; peer review: 3 approved] Wellcome Open Research
2018, 3:64
10.12688/wellcomeopenres.14610.2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.12688/wellcomeopenres.14610.2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>UNAIDS (2021) Global AIDS Update–Confronting Inequalities–Lessons for Pandemic Responses From 40 Years of AIDS. Joint United Nations Programme on HIV/AIDS 2021. https://www.unaids.org/en/resources/documents/2021/2021-global-aids-update.</Citation>
        </Reference>
        <Reference>
          <Citation>Global, regional and national age-sex specific mortality for 264 causes of death 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151–210. doi: 10.1016/S0140-6736(17)32152-9
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(17)32152-9</ArticleId>
            <ArticleId IdType="pmc">PMC5605883</ArticleId>
            <ArticleId IdType="pubmed">28919116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Madhi SA, Nunes MC. The potential impact of pneumococcal conjugate vaccine in Africa: considerations and early lessons learned from the South African experience. Hum Vaccin Immunother
2016; 12:314–25. doi: 10.1080/21645515.2015.1084450
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/21645515.2015.1084450</ArticleId>
            <ArticleId IdType="pmc">PMC5049711</ArticleId>
            <ArticleId IdType="pubmed">26317537</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wall EC, Everett BD, Mukaka M, et al.. Bacterial meningitis in Malawian adults, adolescents, and children during the era of antiretroviral scale-up and haemophilus influenzae type B vaccination, 2000–2012. Clin Infect Dis
2014; 58:e137–45. doi: 10.1093/cid/ciu057
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/ciu057</ArticleId>
            <ArticleId IdType="pmc">PMC4001285</ArticleId>
            <ArticleId IdType="pubmed">24496208</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nhantumbo AA, Weldegebriel G, Katsande R, de Gouveia L, Come´ CE, Cuco AZ, et al.. (2017) Surveillance of impact of PCV-10 vaccine on pneumococcal meningitis in Mozambique, 2013–2015. PLoS ONE
12(6): e0177746. doi: 10.1371/journal.pone.0177746
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0177746</ArticleId>
            <ArticleId IdType="pmc">PMC5467806</ArticleId>
            <ArticleId IdType="pubmed">28604773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Molloy SF, Kanyama C, Heyderman RS, Loyse A, Kouanfack C, Chanda D, et al.. Antifungal combinations for treatment of cryptococcal meningitis in Africa. N Engl J Med. 2018;378(11):1004–17. doi: 10.1056/NEJMoa1710922
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1710922</ArticleId>
            <ArticleId IdType="pubmed">29539274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nhantumbo AA, Cantarelli VV, Caireão J, Munguambe AM, Comé CE, Pinto GdC, et al.. (2015) Frequency of Pathogenic Paediatric Bacterial Meningitis in Mozambique: The Critical Role of Multiplex Real-Time Polymerase Chain Reaction to Estimate the Burden of Disease. PLoS ONE
10(9): e0138249. doi: 10.1371/journal.pone.0138249
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0138249</ArticleId>
            <ArticleId IdType="pmc">PMC4578858</ArticleId>
            <ArticleId IdType="pubmed">26393933</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>INE (2017). IV Recenseamento Geral da População e Habitação em Mocambique.INSTITUTO NACIONAL DE ESTATÍSTICA (http://www.ine.gov.mz/iv-rgph2017/mocambique/apresentacao-resultados-do-censo-2017-1) (acessed in May 2021).</Citation>
        </Reference>
        <Reference>
          <Citation>IMASIDA (2015) Mozambique Survey of Indicators on Immunization, Malaria and HIV/AIDS, https://www.dhsprogram.com/pubs/pdf/AIS12/AIS12_SE.pdf (accessed in May 2021).</Citation>
        </Reference>
        <Reference>
          <Citation>WHO-AFRO. Standard operating procedures for enhanced meningitis surveillance in Africa. World Health Organization Regional Office for Africa, 2009.</Citation>
        </Reference>
        <Reference>
          <Citation>Ouattara M, Whaley MJ, Jenkins LT, et al.. Triplex real-time PCR assay for the detection of Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae directly from clinical specimens without extraction of DNA. Diagn Microbiol Infect Dis
2019; 93:188–90. doi: 10.1016/j.diagmicrobio.2018.10.008
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.diagmicrobio.2018.10.008</ArticleId>
            <ArticleId IdType="pubmed">30413354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sacarlal Jahit, and David W Denning. “Estimated Burden of Serious Fungal Infections in Mozambique.” Journal of fungi (Basel, Switzerland) vol. 4,3 75. 23
Jun. 2018, doi: 10.3390/jof4030075
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/jof4030075</ArticleId>
            <ArticleId IdType="pmc">PMC6162438</ArticleId>
            <ArticleId IdType="pubmed">29937480</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ordi J, Castillo P, Garcia-Basteiro AL, et al.. Clinico-pathological discrepancies in the diagnosis of causes of death in adults in Mozambique: A retrospective observational study. PLoS One. 2019;14(9):e0220657. Published 2019 Sep 6. doi: 10.1371/journal.pone.0220657
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0220657</ArticleId>
            <ArticleId IdType="pmc">PMC6730941</ArticleId>
            <ArticleId IdType="pubmed">31490955</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mullan PC, Steenhoff AP, Draper H, Wedin T, Bafana M, Anabwani G, et al.. Etiology of meningitis among patients admitted to a tertiary referral hospital in Botswana. Pediatr Infect Dis J. 2011;30(7):620–2. doi: 10.1097/INF.0b013e318210b51e
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/INF.0b013e318210b51e</ArticleId>
            <ArticleId IdType="pubmed">21326135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scarborough M, Gordon SB, Whitty CJ, French N, Njalale Y, Chitani A, et al.. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med. 2007;357(24):2441–50. doi: 10.1056/NEJMoa065711
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa065711</ArticleId>
            <ArticleId IdType="pmc">PMC5068549</ArticleId>
            <ArticleId IdType="pubmed">18077809</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wall EC, Everett DB, Mukaka M, Bar-Zeev N, Feasey N, Jahn A, et al.. Bacterial meningitis in Malawian adults, adolescents, and children during the era of antiretroviral scale-up and Haemophilus influenzae type b vaccination, 2000–2012. Clin Infect Dis. 2014;58(10):e137–45. doi: 10.1093/cid/ciu057
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/ciu057</ArticleId>
            <ArticleId IdType="pmc">PMC4001285</ArticleId>
            <ArticleId IdType="pubmed">24496208</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jarvis JN, Harrison TS, Lawn SD, Meintjes G, Wood R, Cleary S. Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa. PLOS One. 2013; 8:e69288. [PubMed: doi: 10.1371/journal.pone.0069288 ].</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0069288</ArticleId>
            <ArticleId IdType="pmc">PMC3716603</ArticleId>
            <ArticleId IdType="pubmed">23894442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Siddiqi OK, Atadzhanov M, Birbeck GL, Koralnik IJ. The spectrum of neurological disorders in a Zambian tertiary care hospital. J Neurol Sci. 2010;290(1–2):1–5. doi: 10.1016/j.jns.2009.12.022
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2009.12.022</ArticleId>
            <ArticleId IdType="pmc">PMC2854137</ArticleId>
            <ArticleId IdType="pubmed">20070986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hakim JG, Gangaidzo IT, Heyderman RS, Mielke J, Mushangi E, Taziwa A, et al.. Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients. AIDS. 2000;14(10):1401–7. doi: 10.1097/00002030-200007070-00013
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00002030-200007070-00013</ArticleId>
            <ArticleId IdType="pubmed">10930155</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kambire D, Soeters HM, Oue´draogo Traore´ R, Medah I, Sangare L, Yame ogo I, et al.. (2016) Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine—Burkina Faso, 2011–2013. PLoS ONE
11(11): e0166384. doi: 10.1371/journal.pone.0166384
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0166384</ArticleId>
            <ArticleId IdType="pmc">PMC5104358</ArticleId>
            <ArticleId IdType="pubmed">27832151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Britz E, Perovic O, von Mollendorf C, von Gottberg A, Iyaloo S, Quan V, et al.. (2016) The Epidemiology of Meningitis among Adults in a South African Province with a High HIV Prevalence, 2009–2012. PLoS ONE
11(9): e0163036. doi: 10.1371/journal.pone.0163036
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0163036</ArticleId>
            <ArticleId IdType="pmc">PMC5036788</ArticleId>
            <ArticleId IdType="pubmed">27669564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tigabu A, Jember A, Nega T, et al.. Bacterial Meningitis Among Adult Patients at University of Gondar Comprehensive Specialized Referral Hospital. Infect Drug Resist. 2021;14:565–574. Published 2021 Feb 15. doi: 10.2147/IDR.S296792
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/IDR.S296792</ArticleId>
            <ArticleId IdType="pmc">PMC7895910</ArticleId>
            <ArticleId IdType="pubmed">33623397</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mackenzie G.A., Hill P.C., Jeffries D.J., Hossain I., Uchendu U., Ameh D.
Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study. Lancet Infect Dis. 2016:703–711. [PMC free article] [PubMed] [Google Scholar]. doi: 10.1016/S1473-3099(16)00054-2
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1473-3099(16)00054-2</ArticleId>
            <ArticleId IdType="pmc">PMC4909992</ArticleId>
            <ArticleId IdType="pubmed">26897105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mackenzie G.A., Hill P.C., Jeffries D.J., Hossain I., Uchendu U., Ameh D.
Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study. Lancet Infect Dis. 2016:703–711. [PMC free article] [PubMed] [Google Scholar]. doi: 10.1016/S1473-3099(16)00054-2
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1473-3099(16)00054-2</ArticleId>
            <ArticleId IdType="pmc">PMC4909992</ArticleId>
            <ArticleId IdType="pubmed">26897105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>von Gottberg A., de Gouveia L., Tempia S., Quan V., Meiring S., von Mollendorf C.
Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med. 2014;371 141111140010002. [PubMed] [Google Scholar]. doi: 10.1056/NEJMoa1401914
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1401914</ArticleId>
            <ArticleId IdType="pubmed">25386897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nanoo A, Izu A, Ismail NA, Ihekweazu C, Abubakar I, Mametja D, et al.. Nationwide and regional incidence of microbiologically confirmed pulmonary tuberculosis in South Africa, 2004–12: a time series analysis. Lancet Infect Dis. 2015; 15(9):1066–76. doi: 10.1016/S1473-3099(15)00147-4 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1473-3099(15)00147-4</ArticleId>
            <ArticleId IdType="pubmed">26112077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>von Gottberg A, de Gouveia L, Tempia S, Quan V, Meiring S, von Mollendorf C, et al.. Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med. 2014; 371(20):1889–99. doi: 10.1056/NEJMoa1401914 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1401914</ArticleId>
            <ArticleId IdType="pubmed">25386897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bekondi C, Bernede C, Passone N, Minssart P, Kamalo C, Mbolidi D, et al.. Primary and opportunistic pathogens associated with meningitis in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus. Int J Infect Dis. 2006;10(5):387–95. [PubMed] [Google Scholar]. doi: 10.1016/j.ijid.2005.07.004
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijid.2005.07.004</ArticleId>
            <ArticleId IdType="pubmed">16473538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schutte CM, Van der Meyden CH, Magazi DS. The impact of HIV on meningitis as seen at a South African Academic Hospital (1994 to 1998). Infection. 2000;28(1):37.</Citation>
        </Reference>
        <Reference>
          <Citation>Rajasingham R, Rhein J, Klammer K, Musubire A, Nabeta H, Akampurira A, et al.. Epidemiology of meningitis in an HIV-infected Ugandan cohort. Am JTrop Med Hyg. 2014:14–0452.</Citation>
        </Reference>
        <Reference>
          <Citation>Tenforde M.W., Wake R., Leeme T., Jarvis J.N.
HIV-Associated Cryptococcal meningitis: Bridging the gap between developed and resource-limited settings. Curr. Clin. Microbiol Rep. 2016;3:92–102. doi: 10.1007/s40588-016-0035-5
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s40588-016-0035-5</ArticleId>
            <ArticleId IdType="pmc">PMC4845086</ArticleId>
            <ArticleId IdType="pubmed">27257597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hakim JG, Gangaidzo IT, Heyderman RS, Mielke J, Mushangi E, Taziwa A, et al.. Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients. AIDS. 2000;14(10):1401–7. doi: 10.1097/00002030-200007070-00013
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00002030-200007070-00013</ArticleId>
            <ArticleId IdType="pubmed">10930155</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masur H.; Brooks J.T.; Benson C.A.; Holmes K.K.; Pau A.K.; Kaplan J.E.; National Institutes of Health; Centers for Disease Control and Prevention; HIV Medicine Association of the Infectious Diseases Society of Americaet al. Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America. Clin. Infect. Dis. 2014, 58, 1308–1311. [PubMed]. doi: 10.1093/cid/ciu094
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/ciu094</ArticleId>
            <ArticleId IdType="pmc">PMC3982842</ArticleId>
            <ArticleId IdType="pubmed">24585567</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson LF. Access to antiretroviral treatment in South Africa, 2004–2011. S Afr J HIV Med. 2012; 13 (1).</Citation>
        </Reference>
        <Reference>
          <Citation>Oladele R.O.; Akanmu A.S.; Nwosu A.O.; Ogunsola F.T.; Richardson M.D.; Denning D.W.
Cryptococcal Antigenemia in Nigerian Patients With Advanced Human Immunodeficiency Virus: Influence of Antiretroviral Therapy Adherence. Open Forum Infect. Dis. 2016, 3, ofw055. [CrossRef] [PubMed]. doi: 10.1093/ofid/ofw055
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ofid/ofw055</ArticleId>
            <ArticleId IdType="pmc">PMC4866571</ArticleId>
            <ArticleId IdType="pubmed">27186581</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ministério da Saúde (MISAU). Relatório Anual das Actividades Relacionadas ao HIV/SIDA (2019), 2019. https://www.misau.gov.mz/index.php/relatorios-anuais#.</Citation>
        </Reference>
        <Reference>
          <Citation>Meya DB, Manabe YC, Castelnuovo B, Cook BA, Elbireer AM, Kambugu A, et al.. Cost-Effectiveness of Serum Cryptococcal Antigen Screening to Prevent Deaths among HIV-Infected Persons with a CD4+ Cell Count &lt;100 Cells/μL Who Start HIV Therapy in Resource-Limited Settings. Clin Infect Dis. 2010; 51(4):448–55. doi: 10.1086/655143 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/655143</ArticleId>
            <ArticleId IdType="pmc">PMC2946373</ArticleId>
            <ArticleId IdType="pubmed">20597693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization. Rapid Advice: Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-Infected Adults, Adolescents and Children: December 2011. 2011. Available online: http://apps.who.int/iris/handle/10665/44786 (accessed on 20 August 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Pongsai P.; Atamasirikul K.; Sungkanuparph S.
The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in HIV-infected patients with different ranges of CD4 cell counts. J. Infect. 2010, 60, 474–477. [CrossRef] [PubMed]. doi: 10.1016/j.jinf.2010.03.015
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jinf.2010.03.015</ArticleId>
            <ArticleId IdType="pubmed">20347868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Osazuwa O.F.; Dirisu O.; Okuonghae E.
Cryptococcal antigenemia in anti-retroviral naïve AIDS patients: Prevalence and its association with CD4 cell count. Acta Med. Iran. 2012, 50, 344–347. [PubMed]. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22837089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cassim N.; Schnippel K.; Coetzee L.M.; Glencross D.K.
Establishing a cost-per-result of laboratorybased, reflex Cryptococcal antigenaemia screening (CrAg) in HIV+ patients with CD4 counts less than 100 cells/μl using a Lateral Flow Assay (LFA) at a typical busy CD4 laboratory in South Africa. PLoS ONE
2017, 12, e0171675. [CrossRef] [PubMed]. doi: 10.1371/journal.pone.0171675
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0171675</ArticleId>
            <ArticleId IdType="pmc">PMC5293213</ArticleId>
            <ArticleId IdType="pubmed">28166254</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ford N, Shubber Z, Jarvis JN, Chiller T, Greene G, Migone C, et al.. CD4 cell count threshold for cryptococcal antigen screening of HIV-infected individuals: a systematic review and meta-analysis. Clin Infect Dis. 2018; 66(suppl_2):S152–S9. doi: 10.1093/cid/cix1143 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/cix1143</ArticleId>
            <ArticleId IdType="pmc">PMC5850628</ArticleId>
            <ArticleId IdType="pubmed">29514236</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
